A High Dose Intravenous Immunoglobulin Therapy for Women with Four or More Recurrent Spontaneous Abortions

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr class="thead"><td align="left">Pregnancy outcome</td><td align="center">Number</td><td align="left">Complications</td><td align="center">Number (%) </td></tr><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td align="left">Live birth</td><td align="center">44</td><td align="left">Premature delivery</td><td align="center">8/44 (18.2) </td></tr><tr><td align="left">IUFD at 31st week</td><td align="center">1</td><td align="left">IUGR</td><td align="center">6/44 (13.6) </td></tr><tr><td align="left">Spontaneous abortion</td><td align="center">15</td><td align="left">Anomaly (cleft lip)</td><td align="center">1 </td></tr><tr><td align="left"> Normal chromosome karyotype</td><td align="center">2</td><td align="left">Adverse effects on mothers<i>　</i></td><td align="center"> </td></tr><tr><td align="left"> Abnormal chromosome karyotype</td><td align="center">11</td><td align="left"> Rash and fever</td><td align="center">4/60 (6.7)</td></tr><tr><td align="left"> Unknown karyotype</td><td align="center">2</td><td align="left"> Elevation of d-dimer</td><td align="center">4/60 (6.7)</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td> IUFD: intrauterine fetal death; IUGR: intrauterine growth restriction. <br/></td></tr></table>

Pregnancy outcome, complications and adverse effects in 60 women with severe cases of unexplained recurrent spontaneous abortion who underwent a high dose intravenous immunoglobulin therapy. <i>　</i>

International Scholarly Research Notices

tab1

Table 1

Table 1: A High Dose Intravenous Immunoglobulin Therapy for Women with Four or More Recurrent Spontaneous Abortions 